Physician profile
Corey Luke
NPI 1396121026
$2,174.42
in general payments reported to CMS, 2019-2025
16 companies · $83.48 in 2025
The $83.48 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $795 · 2022: $235 · 2023: $445 · 2024: $616 · 2025: $83.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Travel and Lodging: $15.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.00 |
| Travel and Lodging | $15.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $739.41 | 2021-2022 | |
| Spr Therapeutics, INC | $343.45 | 2021-2024 | Sprint Pns System |
| Nevro Corp. | $338.18 | 2021-2024 | Senza |
| Boston Scientific Corporation | $205.93 | 2022-2024 | |
| Lilly USA, LLC | $103.30 | 2024 | Mounjaro |
| Nalu Medical, INC. | $99.59 | 2021-2024 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $78.57 | 2023 | Qutenza |
| Abbott Laboratories | $55.98 | 2024 | Eterna |
| Abbvie INC. | $41.81 | 2024 | |
| Globus Medical, INC. | $41.65 | 2025 | Vyrsa V1, Senza |
| Stryker Corporation | $37.60 | 2024 | Spinejack, Optablate |
| Saluda Medical Americas, INC. | $23.42 | 2025 | Evoke |
| Ipsen Biopharmaceuticals, INC | $19.68 | 2024 | Dysport |
| Mml US, INC. | $18.41 | 2025 | Reactiv8 |
| Pacira Pharmaceuticals Incorporated | $13.87 | 2024 | Iovera, Zilretta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Luke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.